Clinical Trials Logo
  1. Home
  2. Common Warts
  3. NCT02798419

Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts

Common Warts Clinical Trial

Clinical Trial Summary

DFD05 vs. Active01 in the treatment of common warts

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02798419
Study type Interventional
Source Dr. Reddys Laboratories, SA
Contact
Status Completed
Phase Phase 2
Start date January 2016
Completion date August 2016
View Details
See also
  Status Clinical Trial Phase
Completed NCT01286441 - A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for Treatment of Common Warts Phase 2
Completed NCT02669862 - A Study of A-101 Solution in Subjects With Common Warts. Phase 2
Active, not recruiting NCT02640820 - Evaluate the Effectiveness and Safety of DPCP Ointment (Samcyprone™) on the Clearance of Verruca Vulgaris (Common Warts) Phase 2
Completed NCT02650466 - Nanopulse Efficacy Study for the Treatment of Common Warts N/A
Not yet recruiting NCT03166137 - Carbon Dioxide Laser and Cryotherapy in Treatment of Warts N/A
Completed NCT02748902 - Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands. Phase 1